Ngā hua rapu - Ren‐Chin Wu
- E whakaatu ana i te 1 - 20 hua o te 34
- Haere ki te Whārangi Whai Ake
-
1
The emerging roles of ARID1A in tumor suppression mā Ren‐Chin Wu, Tian‐Li Wang, Ie‐Ming Shih
I whakaputaina 2014Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
Glucan Binding Protein C of Streptococcus mutans Mediates both Sucrose-Independent and Sucrose-Dependent Adherence mā Joshua L. Mieher, Matt Larson, Norbert Schormann, Sangeetha Purushotham, Ren‐Chin Wu, Kanagalaghatta R. Rajashankar, Hui Wu, Champion Deivanayagam
I whakaputaina 2018Artigo -
9
-
10
-
11
Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors mā A. Ayhan, Tsui‐Lien Mao, Yohan Suryo Rahmanto, Felix Zeppernick, Hiroshi Ogawa, Ren‐Chin Wu, Tian‐Li Wang, Ie‐Ming Shih
I whakaputaina 2015Artigo -
12
ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas mā Ghassan Allo, Marcus Q. Bernardini, Ren‐Chin Wu, Ie‐Ming Shih, Steve E. Kalloger, Aaron Pollett, C. Blake Gilks, Blaise Clarke
I whakaputaina 2013Artigo -
13
HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24 mā Wei Wen Teo, Vanessa F. Merino, Soonweng Cho, Preethi Korangath, Xiaohui Liang, Ren‐Chin Wu, Neil M. Neumann, Andrew J. Ewald, S Sukumar
I whakaputaina 2016Artigo -
14
NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells mā Min Gao, Alice Laschuk Herlinger, Ren‐Chin Wu, Tian‐Li Wang, Ie‐Ming Shih, Beihua Kong, Letícia Batista Azevedo Rangel, Jinming Yang
I whakaputaina 2020Artigo -
15
-
16
Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells mā Yohan Suryo Rahmanto, Jin-Gyoung Jung, Ren‐Chin Wu, Yusuke Kobayashi, Christopher M. Heaphy, Alan K. Meeker, Tian‐Li Wang, Ie‐Ming Shih
I whakaputaina 2016Artigo -
17
CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis mā A. Ayhan, Elisabetta Kuhn, Ren‐Chin Wu, Hiroshi Ogawa, Asli Bahadirli-Talbott, Tsui-Lien Mao, Haruhiko Sugimura, Ie‐Ming Shih, Tian‐Li Wang
I whakaputaina 2016Artigo -
18
Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker mā Kun‐Chun Chiang, Ta‐Sen Yeh, Ren‐Chin Wu, Jong‐Hwei S. Pang, Chi‐Tung Cheng, Shang‐Yu Wang, Horng‐Heng Juang, Chun‐Nan Yeh
I whakaputaina 2016Artigo -
19
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy mā Ren‐Chin Wu, A. Ayhan, Daichi Maeda, Kyu‐Rae Kim, Blaise Clarke, Patricia Shaw, M. Herman Chui, Barry P. Rosen, Ie‐Ming Shih, Tian‐Li Wang
I whakaputaina 2013Artigo -
20
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Genetics
Cancer research
Medicine
Cancer
Gene
Internal medicine
Ovarian cancer
Oncology
Pathology
Biochemistry
Mutation
Carcinoma
Cell biology
ARID1A
Immunology
Carcinogenesis
Clear cell carcinoma
Immunohistochemistry
Endometrial cancer
Immune system
Metastasis
Ovarian carcinoma
Serous fluid
Cell
Ectopic expression
Gene knockdown
Gene silencing
Molecular biology
Receptor